Four days and three boards: there are corresponding development risks for the company to enter the medical and health industry

Four days later, big Oriental replied to the supervision letter. The company has established the strategic positioning of "dual core main business" of modern consumption and health care. Entering the health care industry is a new field for the company, and there will be corresponding development risks. The appraisal value-added rate of the total equity value of the shareholders of "health care" transferred by the company is 936.87%. The appraisal value has increased significantly since August 2019, and there is no comparable company or comparable transaction case in the open market“ Because of the potential uncontrollable factors in the actual market expansion process, the accuracy of the estimated revenue, performance and growth rate of "health care" in the evaluation forecast period is uncertain. The relevant products of Taolu new material company invested by the company are in the cultivation and development stage of transforming scientific research into application and market promotion. From the financial point of view, they are also in the investment period, and will also face the uncertainty factors and corresponding market development risks of transforming scientific research into industrial application.